A15445 | Pages: NA | Jul 2022 | 121 Views | | |
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cri-du-chat Syndrome Treatment Market
Request Now !Cri-du-chat syndrome is a rare genetic condition characterized by the absence of genetic material on the small arm of chromosomes. This missing portion on specific chromosomes has a significant impact on a child’s ability to communicate. This syndrome affects approximately one in every 50,000 infants. Cri-du-chat syndrome is also known as 5p syndrome or the cat cry syndrome. In newborn children, a cat-like cry is the most significant clinical sign for identifying this disorder. Children who have Cri-du-chat syndrome are more likely to seek the assistance of their parents, therapists, and educational professionals. This syndrome is usually associated with babies with a small head, folds of skin across eyelids, low birth weight, small chin, cat-like cry, palate abnormalities, and ear malformation.
COVID-19 Impact Analysis
Pharmaceutical and biotech companies, together with governments globally, are working to address the COVID-19 outbreak from supporting the development of vaccines to planning the medicine supply chain challenges.
Currently, around 115 vaccine samples and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, including Hydroxychloroquine has witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of the COVID-19 management drugs as many developed countries are facing shortages. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the rise in demand for vaccine and treatment drugs for COVID-19. This in turn, is expected to have a significant impact on the global Cri-du-chat syndrome treatment market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish Cri-du-chat syndrome Treatment Market
In January 2020, Quest Diagnostics acquired Blueprint Genetics to enhance its expertise in genetic disorders and rare diseases.
In June 2018, Centogene launched its diagnostic laboratory in Cambridge, Massachusetts.
In February 2020, Dante Labs launched an initiative to offer WGS to patients with rare diseases for $299. The service included WGS 30X on Novaseq6000 technology, data interpretation, and personalized therapy on these diseases
Key Benefits of Report
Questions Answered in Cri-du-chat syndrome Treatment Market Report
Key Market Segments
Segments | Sub-segments |
---|---|
By Treatment |
|
By End User |
|
By Region |
|
Key Market Players
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers